UPDATE 3/9/22: The Defendants now seem to be trying to tighten up the pool of compensable claims – based upon similar litigations, this can be interpreted as a prelude to settlement. On February 28, 2022, the MDL Court entered a Pretrial Order essentially seeking to identify and winnow down all of the claims that can properly be filed in federal court and all of the claims with designated cancers (bladder, esophageal, gastric/stomach, liver, and pancreatic). In this manner, the Defendants are also basically trying to limit, and make it much harder to pursue, both claims against retail and generic defendants, as well as claims involving non-designated primary cancers. This is all set against the backdrop of Defendants’ not so subtle efforts to enforce a definite statute of limitations in the litigation (remember that the market withdrawal of Zantac occurred back on April 1, 2020).
UPDATE 1/27/22: Pursuant to the MDL Court’s directives, on January 25, 2022, Plaintiffs’ filed a final disclosure of the types of cancer for which their experts were able to supply general causation reports. Those cancers are: 1) bladder; 2) esophageal; 3) gastric (stomach); 4) liver; and 5) pancreatic. This means that Plaintiffs’ current experts were unable to support claims of other types of cancers (kidney, breast, lung, prostate, etc.) at this time and that the future viability of any other cancer cases is in question.
Zantac is the brand name of a common heartburn medication called ranitidine. Ranitidine is a type of drug known as an H2 blocker, or H2 antagonist, which decreases stomach acid by blocking histamine receptors in the stomach. Accordingly, ranitidine can be used to treat peptic ulcers, gastroesophageal reflux disease, and related conditions.
Unfortunately, there have been multiple and ongoing recalls of ranitidine, after the testing of certain lots of the drug showed unacceptable levels of the probable human carcinogen N-nitrosodimethylamine (NDMA). However, based upon additional recent testing by a popular independent laboratory and resulting petition filed with the Federal Drug Administration (FDA), there are now claims that ranitidine, itself, causes high levels of NDMA exposure in patients. Essentially, the claims are that the unstable ranitidine molecule breaks down in the digestive tract to create harmful levels of NDMA. Thus, significant NDMA exposure would result from taking brand name or generic ranitidine, regardless of where it was manufactured.
Recent tests appear to show that Zantac (ranitidine) may have been tainted with NDMA, a potentially cancer causing impurity, due to the breakdown of the unstable ranitidine molecule when exposed to heat and other environmental factors. Moreover, that breakdown may continue and intensify in the human body, once the drug is consumed. Similar types of NDMA exposure have been linked to various cancers, including:
And, in more limited circumstances:
Accordingly, ranitidine has been the subject of voluntary recalls and a petition filed with the FDA seeking to halt the sale of ranitidine containing medications.
If you believe you have taken Zantac (ranitidine) and suffered one of these Zantac cancer injuries, an experienced Zantac attorney at Stark & Stark can help you assess your potential claims. Contact a Stark & Stark Zantac attorney now for a free consultation.
If you or a loved one have taken Zantac (ranitidine) and suffered an injury, it is strongly recommended that you seek counsel with a Stark & Stark Zantac attorney, who is experienced in Zantac cancer lawsuits, claims, and injuries.
Stark & Stark attorneys are actively seeking Zantac cancer settlements and filing Zantac cancer lawsuits against drug makers on behalf of patients injured by these potentially defective drugs.
Do not wait – there are different deadlines and statutes of limitations that apply to your potential claim. Let us review your potential claim at no cost to you. Contact a Stark & Stark Zantac cancer lawyer immediately.
Stark & Stark is committed to holding drug and medical device manufacturers liable when their products improperly endanger the public. If you or a member of your family has suffered injuries from taking Zantac (ranitidine), you may be entitled to compensation under the litigation process or via settlement.
We are not a marketing group. Stark & Stark is a law firm comprised of experienced trial lawyers. Stark & Stark is a national law firm pursuing thousands of cases throughout the country. We have been in business for over 80 years and have over 100 attorneys in offices located throughout New Jersey, Pennsylvania and New York.
Our Zantac lawsuit lawyers are experienced in pharmaceutical litigation cases and in negotiating with medical device and pharmaceutical settlement representatives. Let us help you.
Please contact Stark & Stark to speak with a Zantac attorney, free of charge, who can help assess any claims that you may have and to help you understand the Zantac settlement and lawsuit process. We specialize in Zantac settlements, allow us to help you today.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...
